12/5
06:24 am
imtx
Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]
Medium
Report
Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]
12/5
06:13 am
imtx
Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]
Medium
Report
Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]
12/5
06:00 am
imtx
Immatics Announces $125 Million Underwritten Offering
High
Report
Immatics Announces $125 Million Underwritten Offering
12/4
08:12 am
imtx
Immatics (NASDAQ:IMTX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
High
Report
Immatics (NASDAQ:IMTX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
11/24
11:04 am
imtx
Immatics (NASDAQ:IMTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
Low
Report
Immatics (NASDAQ:IMTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
11/19
09:37 am
imtx
Immatics (NASDAQ:IMTX) had its price target raised by analysts at Mizuho from $19.00 to $23.00. They now have an "outperform" rating on the stock.
Low
Report
Immatics (NASDAQ:IMTX) had its price target raised by analysts at Mizuho from $19.00 to $23.00. They now have an "outperform" rating on the stock.
11/18
09:34 am
imtx
Immatics (NASDAQ:IMTX) had its price target raised by analysts at Guggenheim from $16.00 to $19.00. They now have a "buy" rating on the stock.
Medium
Report
Immatics (NASDAQ:IMTX) had its price target raised by analysts at Guggenheim from $16.00 to $19.00. They now have a "buy" rating on the stock.
11/18
06:19 am
imtx
Should Immatics' (IMTX) New Clinical Data on IMA402 and IMA401 Prompt Fresh Investor Attention? [Yahoo! Finance]
Medium
Report
Should Immatics' (IMTX) New Clinical Data on IMA402 and IMA401 Prompt Fresh Investor Attention? [Yahoo! Finance]
11/17
07:22 am
imtx
Immatics Announces Third Quarter 2025 Financial Results and Business Update [Yahoo! Finance]
Medium
Report
Immatics Announces Third Quarter 2025 Financial Results and Business Update [Yahoo! Finance]
11/17
07:00 am
imtx
Immatics Announces Third Quarter 2025 Financial Results and Business Update
Medium
Report
Immatics Announces Third Quarter 2025 Financial Results and Business Update
11/12
07:00 am
imtx
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
High
Report
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
10/29
09:03 am
imtx
Immatics (NASDAQ:IMTX) was given a new $19.00 price target on by analysts at Mizuho.
Low
Report
Immatics (NASDAQ:IMTX) was given a new $19.00 price target on by analysts at Mizuho.
10/27
07:00 am
imtx
Immatics Appoints Amie Krause as Chief People Officer
Medium
Report
Immatics Appoints Amie Krause as Chief People Officer
10/20
10:30 am
imtx
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
Medium
Report
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
10/15
07:10 am
imtx
Immatics (NASDAQ:IMTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Immatics (NASDAQ:IMTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
10/10
10:29 am
imtx
Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 [Seeking Alpha]
Low
Report
Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 [Seeking Alpha]
10/8
12:25 pm
imtx
Immatics (NASDAQ:IMTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Immatics (NASDAQ:IMTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
08:16 am
imtx
Immatics appoints industry veteran as CFO [Seeking Alpha]
Low
Report
Immatics appoints industry veteran as CFO [Seeking Alpha]
10/1
08:10 am
imtx
Navigating the new normal: CFOs manage uncertainty as talent remains a big worry [Fortune]
Low
Report
Navigating the new normal: CFOs manage uncertainty as talent remains a big worry [Fortune]
10/1
07:38 am
imtx
Immatics Appoints Venkat Ramanan as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Immatics Appoints Venkat Ramanan as Chief Financial Officer [Yahoo! Finance]
10/1
07:00 am
imtx
Immatics Appoints Venkat Ramanan as Chief Financial Officer
Medium
Report
Immatics Appoints Venkat Ramanan as Chief Financial Officer
9/18
09:14 am
imtx
Immatics (NASDAQ:IMTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $16.00 price target on the stock.
Medium
Report
Immatics (NASDAQ:IMTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $16.00 price target on the stock.